A Dual-Energy Computed Tomography Guided Intelligent Radiation Therapy Platform.

Int J Radiat Oncol Biol Phys

The SJTU-Ruijin-UIH Institute for Medical Imaging Technology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Radiation Oncology, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Proton Therapy, Shanghai, China. Electronic address:

Published: February 2025

Purpose: The integration of advanced imaging and artificial intelligence technologies in radiation therapy has revolutionized cancer treatment by enhancing precision and adaptability. This study introduces a novel dual-energy computed tomography (DECT) guided intelligent radiation therapy (DEIT) platform designed to streamline and optimize the radiation therapy process. The DEIT system combines DECT, a newly designed dual-layer multileaf collimator, deep learning algorithms for auto-segmentation, and automated planning and quality assurance capabilities.

Methods And Materials: The DEIT system integrates an 80-slice computed tomography (CT) scanner with an 87 cm bore size, a linear accelerator delivering 4 photon and 5 electron energies, and a flat panel imager optimized for megavoltage (MV) cone beam CT acquisition. A comprehensive evaluation of the system's accuracy was conducted using end-to-end tests. Virtual monoenergetic CT images and electron density images of the DECT were generated and compared on both phantom and patient. The system's auto-segmentation algorithms were tested on 5 cases for each of the 99 organs at risk, and the automated optimization and planning capabilities were evaluated on clinical cases.

Results: The DEIT system demonstrated systematic errors of less than 1 mm for target localization. DECT reconstruction showed electron density mapping deviations ranging from -0.052 to 0.001, with stable Hounsfield unit consistency across monoenergetic levels above 60 keV, except for high-Z materials at lower energies. Auto-segmentation achieved dice similarity coefficients above 0.9 for most organs with an inference time of less than 2 seconds. Dose-volume histogram comparisons showed improved dose conformity indices and reduced doses to critical structures in auto-plans compared to manual plans across various clinical cases. In addition, high gamma passing rates at 2%/2 mm in both 2-dimensional (above 97%) and 3-dimensional (above 99%) in vivo analyses further validate the accuracy and reliability of treatment plans.

Conclusions: The DEIT platform represents a viable solution for radiation treatment. The DEIT system uses artificial intelligence-driven automation, real-time adjustments, and CT imaging to enhance the radiation therapy process, improving efficiency and flexibility.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2025.01.028DOI Listing

Publication Analysis

Top Keywords

radiation therapy
20
deit system
16
computed tomography
12
dual-energy computed
8
guided intelligent
8
intelligent radiation
8
deit platform
8
therapy process
8
electron density
8
radiation
6

Similar Publications

Boron Neutron Capture Therapy (BNCT) leverages the nuclear reaction between boron-10 and thermal neutrons to selectively destroy cancer cells while minimizing damage to surrounding healthy tissues. This therapy has found use in treating glioblastoma, which as a brain cancer, is difficult to treat using conventional radiotherapy, surgery, and chemotherapy due to location and the risk of brain damage. However, to work, the cells must contain 10B.

View Article and Find Full Text PDF

[Merkel cell carcinoma: An update].

Bull Cancer

March 2025

Dermatologie, CHU de Tours, Tours, France; Réseau CARADERM, France.

Merkel cell carcinoma (MCC) is a rare skin cancer that mainly affects the elderly, and whose incidence is increasing. Although the exact origin of this cancer remains uncertain, research in recent years has revealed that MCC develops through two oncogenesis pathways: virally induced by the Merkel polyomavirus (80% of cases) and induced by mutations linked to ultraviolet rays (20% of cases). MCC is an aggressive cancer, with a high mortality rate and limited therapeutic options in advanced stage.

View Article and Find Full Text PDF

Primary cutaneous/subcutaneous Ewings sarcoma.

Bull Cancer

March 2025

Pediatric Oncology, insitut Gustave-Roussy, Villejuif, France. Electronic address:

Amongst Ewing sarcoma family of tumours, (EFST), cutaneous/subcutaneous Ewing sarcoma are defined as tumours arising from cutaneous or subcutaneous tissue, not invading the underlying aponeurosis. They are rare tumours, with less than 200 patients published. They are typically small tumours (less than 5cm), and can arise at any anatomical location, with a particular tropism for distal, truncal and head/neck locations, compared to classical Ewing sarcoma.

View Article and Find Full Text PDF

Patients who develop Ewing sarcoma with extra-pulmonary metastasis have a poor prognosis. A recent French protocol, CombinaiR3, was set up to evaluate the efficacy of induction chemotherapy followed by high-dose chemotherapy and metronomic maintenance treatment. It is now closed for inclusions and while waiting for the results, we propose a French consensus guideline for the management of patients diagnosed with Ewing sarcoma with extra-pulmonary dissemination.

View Article and Find Full Text PDF

Cytokine therapy of acute radiation syndrome.

Best Pract Res Clin Haematol

December 2024

Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, SW7 2AZ, UK.

Radiological accidents/incidents are common with nearly 400 reported since 1944 exposing about 3000 people to substantial doses of ionizing radiations with 127 deaths. Damage to hematopoietic stem and progenitor cells with resulting bone marrow failure is a common consequence of exposure to whole body acute high-dose and -dose-rate ionizing radiations and is termed hematopoietic-acute radiation syndrome, or H-ARS. Therapy of H-ARS includes transfusions, anti-bacterial and -viral drugs, molecularly-cloned hematopoietic growth factors and hematopoietic cell transplants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!